Connect
Hi, Iβm Santosh D. Bhosale
A pharmacist-turned-proteomics scientist with a PhD and 15+ years of experience spanning wet-lab mass spectrometry, computational proteomics, and β most recently β AI/ML for drug discovery. I bridge deep domain biology with scalable data pipelines.
20+
Peer-reviewed publications
15+
Years research experience
10+
Peer-reviewed manuscripts
1
Patent application (EU & USA)
Currently: Product Manager I (Growth) at Partex.ai (Formerly Innoplexus Consulting Pvt. Ltd.), Pune β leading biomarker module development for omics data, integrating Llama & Gemini LLMs with Python pipelines to accelerate pharmaceutical drug discovery.
What I Do - Proteomics Meets Artificial Intelligence
π¬ Proteomics Research
Mass spectrometry-based proteomics (DIA/DDA), PTM enrichment (phospho, glyco, cysteine), biomarker discovery from serum/plasma, label-free & isobaric quantification (TMT/iTRAQ).
π€ AI/ML for Drug Discovery
LLM-based data extraction (Llama, Gemini) from ClinicalTrials.gov & PubChem, Python automation for biocuration, ML pipeline development, agile collaboration with data engineers.
π¦ Product & Project Management
End-to-end delivery of omics projects (SOW to deliverable), cross-functional team leadership, biomarker module product ownership, stakeholder and vendor management.
Career Highlights
| Year | Role | Organisation | Location |
|---|---|---|---|
| 2025βpresent | Product Manager I β Growth | Partex.ai (Formerly Innoplexus Consulting Pvt. Ltd.) | Pune, India |
| 2024 | Associate Scientific Manager | Partex.ai (Formerly Innoplexus Consulting Pvt. Ltd.) | Pune, India |
| 2023β2024 | Associate Biomedical Scientist | Cedars-Sinai Precision Biomarker Laboratories | Los Angeles, USA |
| 2020β2022 | Postdoctoral Researcher | University of Southern Denmark | Odense, Denmark |
| 2018β2019 | Postdoctoral Researcher | University of Turku β Turku Bioscience | Turku, Finland |
| 2012β2018 | PhD | University of Turku | Turku, Finland |
Selected Publications
Hendricks NG, Bhosale SD, et al. (2024). An Inflection Point in High-Throughput Proteomics with Orbitrap Astral: Analysis of Biofluids, Cells, and Tissues. J Proteome Res
Bhosale SD, Moulder R, et al. (2024). Serum proteomics of mother-infant dyads carrying HLA-conferred type 1 diabetes risk. iScience
Moulder R, Bhosale SD, et al. (2018). Analysis of the plasma proteome using iTRAQ and TMT-based isobaric labeling. Mass Spectrometry Reviews
Bhosale SD, Moulder R, et al. (2018). Serum Proteomic Profiling to Identify Biomarkers of Premature Carotid Atherosclerosis. Sci Rep
Moulder R, Bhosale SD, et al. (2015). Serum proteomes distinguish children developing type 1 diabetes in a cohort with HLA-conferred susceptibility. Diabetes
π View all 20+ publications and patent β
Awards
π Doctoral Dissertation Award β Orion Pharma, β¬5,000 (2018)
π Doctoral Dissertation Award β Maud Kuistila Memorial Foundation, β¬5,000 (2018)
π Research Grant β Hospital District of Southwest Finland & Turku City, β¬3,500 (2014)
βοΈ Travel Grant β Turku Centre for Systems Biology, ETH ZΓΌrich Proteomics Course, β¬500 (2015)
π₯ Dr. Ashok B. Vaidya Prize β 1st place, SAACCP Oral Session (2009)